| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 12 | +0.00% | +13.16% | -3.16% | +16.32% | +12.44% | — |
| 14d | 12 | +75.00% | +13.76% | -3.83% | +17.59% | +0.79% | — |
| 30d | 12 | +0.00% | +25.42% | +1.02% | +24.40% | +11.61% | — |
| 60d | 12 | +0.00% | +13.16% | +4.25% | +8.92% | +8.92% | — |
| 90d | 12 | +0.00% | +27.30% | +9.21% | +20.24% | +20.24% | — |
| 180d | 12(3 pending) | +100.00% | -15.64% | +16.95% | -32.59% | -32.59% | — |
| 1y | 12(3 pending) | +100.00% | -55.41% | +11.82% | -67.22% | -67.22% | — |
| 2y | 12(12 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 39,823 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 13,800 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 110,000 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 11,900 | — | — | 0 | May 18, 2026 | May 18, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 488 | $31.72 | $15.5K | 39,823 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 4,256 | $30.04 | $127.8K | 42,149 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 1,838 | $31.04 | $57.0K | 40,311 | Mar 27, 2026 | Mar 31, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 10,400 | — | — | 46,405 | Jan 21, 2026 | Jan 23, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 11,900 | — | — | 11,900 | Jan 21, 2026 | Jan 23, 2026 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 812 | $49.95 | $40.6K | 36,005 | Dec 15, 2025 | Dec 17, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 125 | $71.74 | $9.0K | 36,836 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 836 | $69.84 | $58.4K | 37,047 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 19 | $72.64 | $1.4K | 36,817 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 86 | $70.73 | $6.1K | 36,961 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASE Sr. VP of Clinical Development | 10,000 | $21.93 | $219.3K | 46,817 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 1,098 | $67.70 | $74.3K | 39,327 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 10,000 | — | — | 110,000 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 10,000 | $70.03 | $700.3K | 36,817 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 1,444 | $68.79 | $99.3K | 37,883 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 371 | $65.97 | $24.5K | 41,029 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | SALE Sr. VP of Clinical Development | 604 | $66.79 | $40.3K | 40,425 | Mar 27, 2025 | Mar 31, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 13,800 | — | — | 13,800 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 6,400 | — | — | 41,400 | Jan 21, 2025 | Jan 23, 2025 ↗ | View → |
| SLNO SOLENO THERAPEUTICS INC | PURCHASEGRANT Stock grant | 35,000 | — | — | 35,000 | Jul 17, 2024 | Jul 19, 2024 ↗ | View → |